Circulating Tumor Cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-41761-5_15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Diagnostics

  2017cited by this paper
• Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer

  2015cited by this paper
• A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer

  2014cited by this paper
• Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients

  2014cited by this paper
• Biology, detection, and clinical implications of circulating tumor cells

  2014cited by this paper
• Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

  2014cited by this paper
• Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

  2014cited by this paper
• Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.

  2014cited by this paper
• Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.

  2014cited by this paper
• Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

  2014cited by this paper
• Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients

  2014cited by this paper
• An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer.

  2014cited by this paper
• Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

  2013cited by this paper
• Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trial.

  2013cited by this paper
• Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells

  2013cited by this paper
• Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.

  2013cited by this paper
• Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

  2013cited by this paper
• Isolation and retrieval of circulating tumor cells using centrifugal forces

  2013cited by this paper
• Clinical application of circulating tumor cells in breast cancer

  2013cited by this paper
• Detecting Circulating Tumor Cells: Current Challenges and New Trends

  2013cited by this paper
• Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

  2013cited by this paper
• The epigenetics of epithelial-mesenchymal plasticity in cancer

  2013cited by this paper
• Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

  2012cited by this paper
• Challenges in the Enumeration and Phenotyping of CTC

  2012cited by this paper
• A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

  2012cited by this paper
• Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

  2012cited by this paper
• Circulating Tumor Cells Detected by RT-PCR for CK-20 before Surgery Indicate Worse Prognostic Impact in Triple-Negative and HER2 Subtype Breast Cancer

  2012cited by this paper
• Dormancy in breast cancer.

  2012cited by this paper
• Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients

  2012cited by this paper
• High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.

  2012cited by this paper
• User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system

  2012cited by this paper
• Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis

  2012cited by this paper
• RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.

  2012cited by this paper
• The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer

  2012cited by this paper
• Circulating tumour cells in non-metastatic breast cancer: a prospective study.

  2012cited by this paper
• Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

  2012cited by this paper
• Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system

  2012cited by this paper
• Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

  2012cited by this paper
• Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

  2012cited by this paper
• Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients

  2012cited by this paper
• EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.

  2012cited by this paper
• Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

  2011cited by this paper
• Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

  2011cited by this paper
• Circulating tumor cells: approaches to isolation and characterization

  2011cited by this paper
• Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

  2011cited by this paper
• Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

  2011cited by this paper
• Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

  2011cited by this paper
• Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.

  2011cited by this paper
• Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.

  2011cited by this paper
• Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

  2011cited by this paper
• The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

  2011cited by this paper
• Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

  2010cited by this paper
• Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

  2010cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

  2010cited by this paper
• HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

  2010cited by this paper
• Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients

  2010cited by this paper
• Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

  2010cited by this paper
• Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

  2009cited by this paper
• HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

  2009cited by this paper
• Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

  2009cited by this paper
• Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

  2009cited by this paper
• Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.

  2009cited by this paper
• Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.

  2009cited by this paper
• ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

  2008cited by this paper
• Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.

  2008cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

  2008cited by this paper
• Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

  2008cited by this paper
• Detection, clinical relevance and specific biological properties of disseminating tumour cells

  2008cited by this paper
• Systemic spread is an early step in breast cancer.

  2008cited by this paper
• Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment

  2008cited by this paper
• Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

  2008cited by this paper
• Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?

  2008cited by this paper
• The Metastasis Cascade

  2008cited by this paper
• Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

  2007cited by this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

  2007cited by this paper
• Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

  2006cited by this paper
• A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

  2006cited by this paper
• Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients

  2006cited by this paper
• Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

  2006cited by this paper
• Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.

  2005cited by this paper
• Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

  2005cited by this paper
• HER-2 gene amplification can be acquired as breast cancer progresses.

  2004cited by this paper
• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Circulating Tumor Cells in Patients with Breast Cancer Dormancy

  2004cited by this paper

• No citing papers are available for this paper.